Dottie Norris

Phase I trial of XR9576 in healthy volunteers demonstrates modulation of P-glycoprotein in CD56+ lymphocytes after oral and intravenous administration.

Alistair Stewart, JA Steiner, G. Mellows et al. · PubMed · 2000 · 122 citations

Clinical Immunology, Intravenous Administration, Immunology +19

CHF5074 Reduces Biomarkers of Neuroinflammation in Patients with Mild Cognitive Impairment: A 12-Week, Double-Blind, Placebo- Controlled Study

Gabriella Bottini, M Franceschi, Elio Scarpini et al. · Current Alzheimer Research · 2013 · 76 citations

Granulocyte transfusion therapy and amphotericin B: Adverse reactions?

Janice P. Dutcher, Joyce Kendall, Dottie Norris et al. · American Journal of Hematology · 1989 · 55 citations

Pharmacokinetics and Pharmacodynamics of CHF5074 After Short-term Administration in Healthy Subjects

Bruno P. Imbimbo, E. Frigerio, Massimo Breda et al. · Alzheimer Disease & Associated Disorders · 2012 · 37 citations

Healthy Subjects, Short-term Administration, Neurochemical Biomarkers +18

Intravenous immune globulin for patients alloimmunized to random donor platelet transfusion

E.J. Lee, Dottie Norris, Charles A. Schiffer · Transfusion · 1987 · 35 citations